Influence of Dosing Interval and Administration on the Bone Metabolism, Skeletal Effects, and Clinical Efficacy of Parathyroid Hormone in Treating Osteoporosis: A Narrative Review

Recombinant human parathyroid hormone (PTH) is the key anabolic agent used for preventing fracture in postmenopausal women with osteoporosis. In bone metabolism, PTH signaling is mediated through a G protein–coupled receptor that affects various post‐receptor signaling pathways. Results of preclinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyoung Min, Lee, Sae Young, Rhee, Yumie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124169/
https://www.ncbi.nlm.nih.gov/pubmed/30283879
http://dx.doi.org/10.1002/jbm4.10005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124169/
https://www.ncbi.nlm.nih.gov/pubmed/30283879
http://dx.doi.org/10.1002/jbm4.10005

Ejemplares similares